References
- D. R. Vega, G. Polla, A. Martinez, E. Mendioroz and M. Reionoso, Conformational polymorphism in bicalutamide, Int. J. Pharm. 328 (2007) 112-118; DOI: 10.1016/j.ijpharm.2006.08.001.10.1016/j.ijpharm.2006.08.00116978811
- D. Wu, J. Yang, V. A. Nair, D. D. Miller and J. T. Dalton, Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic chrecteristics of a propanamide in preclinical study, Drug Metab. Dispos. 34 (2006) 483-494; DOI: 10.1124/dmd.105.006643.10.1124/dmd.105.006643203987716381665
- Y. Le, H. Ji, J. F. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents, Int. J. Pharm. 370 (2009) 175-180; DOI: 10.1016/j.ijpharm.2008.11.025.10.1016/j.ijpharm.2008.11.02519101616
- A. Abdalla and K. Mäder, Preparation and characterization of a self-emulsifying pellet formulation, Eur. J. Pharm. Biopharm. 66 (2007) 220-226; DOI: 10.1016/j.ejpb.2006.11.015.10.1016/j.ejpb.2006.11.01517196807
- I. Kanfer, Report on the international workshop on the biopharmaceutics classification system (BCS): scientific and regulatory aspects in practice, J. Pharm. Pharm. Sci. 5 (2000) 1-4.
- P. Kocbek, S. Baumgartner and J. Kristl, Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs, Int. J. Pharm. 312 (2006) 179-186; DOI: 10.1016/j.ijpharm.2006.01.008.10.1016/j.ijpharm.2006.01.00816469459
- Y. Dong, W. N. Kiong, S. Shen, S. Kim and R. B. H. Tan, Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation, Int. J. Pharm. 375 (2009) 84-88; DOI: 10.1016/j.ijpharm.2009.03.013.10.1016/j.ijpharm.2009.03.01319481693
- A. Balakrishnan, B. D. Rege, G. L. Amidon and J. E. Polli, Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity, J. Pharm. Sci. 93 (2004) 2064-2075; DOI: 10.1002/jps.20118.10.1002/jps.2011815236455
- G. S. Jadhav and P. R. Vavia, Physicochemical in silico and in-vivo evaluation of danazole-β-cyclodextrin complex, Int. J. Pharm. 352 (2008) 5-16 DOI: 10.1016/j.ijpharm.2007.10.005.10.1016/j.ijpharm.2007.10.00518023545
- I. Ilić, R. Dreu, M. Burjak, M. Homar, J. Kerč and J. S. Srčič, Microparticle size control and glimepiride microencapsulation using spray congealing technology, Int. J. Pharm. 381 (2009) 176-183; DOI: 10.1016/j.ijpharm.2009.05.011.10.1016/j.ijpharm.2009.05.01119446625
- M. D. Moore and P. L. D. Wildfong, Aqueous solubility enhancement through engineering of binary solid composites: pharmaceutical applications, J. Pharm. Innov. 4 (2009) 36-49; DOI: 10.1007/s12247-009-9053-7.10.1007/s12247-009-9053-7
- P. Zhang, H. Ye, T. Min and C. Zhang, Water soluble poly(ethylene glycol) prodrug of silybin: design, synthesis, and characterization, J. Appl. Polym. Sci. 107 (2008) 3230-3235; DOI: 10.1002/app.27450.10.1002/app.27450
- Y. Le, H. Ji, J. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents, Int. J. Pharm. 370 (2009) 175-180 DOI: 10.1016/j.ijpharm.2008.11.025.10.1016/j.ijpharm.2008.11.02519101616
- R. P. Bagwe and K. C. Khilar, Effects of the intermicellar exchange rate and cations on the size of silver chloride nanoparticles formed in reverse micelles of AOT, Langmuir 13 (1997) 6432-6438; DOI: 10.1021/la980248q.10.1021/la980248q
- J. Y. Zhang, Z. G. Shen, J. Zhong, T. T. Hu, J. F. Chen, Z. Q. Ma and J. Yun, Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants, Int. J. Pharm. 323 (2006) 153-160; DOI: 10.1016/i.ijpharm.2006.05.048.
- U. S. Food and Drug Administration, Dissolution Methods, Bicalutamide, FDA, Silver Sping (MD), Dec 15 2005; http://www.accessdata.fda.(MD)gov/scripts/cder/dissolution/dsp_Search-Results_Dissolutions.cfm?PrintAll=1